Icon Cancer Centre

South Brisbane, Queensland 4101

4 studies enrolling now · 5 studies all time

What they study most

Angioimmunoblastic T-cell Lymphoma, Colorectal Cancer, Follicular T-Cell Lymphoma, Glioblastoma Multiforme, IDH1-Mutated Malignancies, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype, Peripheral T-Cell Lymphoma, Not Otherwise Specified, Platinum-resistant Ovarian Cancer, Systemic Anaplastic Large Cell Lymphoma

Studies at this site

• A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal Impairment — Recruiting now
• A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer — Recruiting now
• A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer. — Recruiting now
• Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma — Recruiting now
• Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM — Running, not enrolling